Literature DB >> 22519815

Adenosine modification may be preferred for reducing siRNA immune stimulation.

Raymond V Fucini1, Henry J Haringsma, Patricia Deng, W Michael Flanagan, Aarron T Willingham.   

Abstract

The immune stimulation induced by short interfering RNAs (siRNAs) has been reported to be quieted or abrogated by methoxy or fluoro modifications of the 2' position of the ribose sugar. However, variables such as the type of modification, nucleotide preference, and strand bias have not been systematically evaluated. Here, we report the results of a screen of several modified siRNAs via a human peripheral blood monocyte cytokine induction assay. Unlike corresponding modifications of guanosine, cytidine, or uridine, 2'-fluoro modification of adenosine significantly reduced cytokine induction while retaining siRNA knockdown activity. The results of this study suggest adenosine as an optimal target for modification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22519815      PMCID: PMC4047996          DOI: 10.1089/nat.2011.0334

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  21 in total

1.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

2.  Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.

Authors:  Charles R Allerson; Namir Sioufi; Russell Jarres; Thazha P Prakash; Nishant Naik; Andres Berdeja; Lisa Wanders; Richard H Griffey; Eric E Swayze; Balkrishen Bhat
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

3.  Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.

Authors:  Adam D Judge; Gurneet Bola; Amy C H Lee; Ian MacLachlan
Journal:  Mol Ther       Date:  2005-12-15       Impact factor: 11.454

4.  Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNA.

Authors:  Hayden Peacock; Raymond V Fucini; Prasanna Jayalath; José M Ibarra-Soza; Henry J Haringsma; W Michael Flanagan; Aarron Willingham; Peter A Beal
Journal:  J Am Chem Soc       Date:  2011-06-01       Impact factor: 15.419

5.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.

Authors:  David V Morrissey; Jennifer A Lockridge; Lucinda Shaw; Karin Blanchard; Kristi Jensen; Wendy Breen; Kimberly Hartsough; Lynn Machemer; Susan Radka; Vasant Jadhav; Narendra Vaish; Shawn Zinnen; Chandra Vargeese; Keith Bowman; Chris S Shaffer; Lloyd B Jeffs; Adam Judge; Ian MacLachlan; Barry Polisky
Journal:  Nat Biotechnol       Date:  2005-07-24       Impact factor: 54.908

6.  Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA.

Authors:  Adam D Judge; Vandana Sood; Janet R Shaw; Dianne Fang; Kevin McClintock; Ian MacLachlan
Journal:  Nat Biotechnol       Date:  2005-03-20       Impact factor: 54.908

7.  Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects.

Authors:  Lina Cekaite; Gro Furset; Eivind Hovig; Mouldy Sioud
Journal:  J Mol Biol       Date:  2006-09-16       Impact factor: 5.469

8.  Positional effect of chemical modifications on short interference RNA activity in mammalian cells.

Authors:  Thazha P Prakash; Charles R Allerson; Prasad Dande; Timothy A Vickers; Namir Sioufi; Russell Jarres; Brenda F Baker; Eric E Swayze; Richard H Griffey; Balkrishen Bhat
Journal:  J Med Chem       Date:  2005-06-30       Impact factor: 7.446

9.  Synthesis, deprotection, analysis and purification of RNA and ribozymes.

Authors:  F Wincott; A DiRenzo; C Shaffer; S Grimm; D Tracz; C Workman; D Sweedler; C Gonzalez; S Scaringe; N Usman
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

10.  RNA interference tolerates 2'-fluoro modifications at the Argonaute2 cleavage site.

Authors:  Pirkko Muhonen; Tuula Tennilä; Elena Azhayeva; Ranga N Parthasarathy; Anthony J Janckila; H Kalervo Väänänen; Alex Azhayev; Tiina Laitala-Leinonen
Journal:  Chem Biodivers       Date:  2007-05       Impact factor: 2.408

View more
  10 in total

1.  Base modification strategies to modulate immune stimulation by an siRNA.

Authors:  Rachel Anne P Valenzuela; Scott R Suter; Alexi A Ball-Jones; José M Ibarra-Soza; Yuxuan Zheng; Peter A Beal
Journal:  Chembiochem       Date:  2014-12-08       Impact factor: 3.164

2.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

Review 3.  Strategic applications of gene expression: from drug discovery/development to bedside.

Authors:  Jane P F Bai; Alexander V Alekseyenko; Alexander Statnikov; I-Ming Wang; Peggy H Wong
Journal:  AAPS J       Date:  2013-01-15       Impact factor: 3.603

4.  Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy.

Authors:  Varun Kumar; June Qin; Yongfeng Jiang; Richard G Duncan; Benjamin Brigham; Shannon Fishman; Jayaprakash K Nair; Akin Akinc; Scott A Barros; Pia V Kasperkovitz
Journal:  Mol Ther Nucleic Acids       Date:  2014-11-18       Impact factor: 10.183

5.  2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.

Authors:  Wen Shen; Xue-Hai Liang; Hong Sun; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2015-04-08       Impact factor: 16.971

Review 6.  Therapeutic siRNA: state of the art.

Authors:  Bo Hu; Liping Zhong; Yuanyu Huang; Yuhua Weng; Ling Peng; Yongxiang Zhao; Xing-Jie Liang
Journal:  Signal Transduct Target Ther       Date:  2020-06-19

Review 7.  Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides.

Authors:  Steven Ochoa; Valeria T Milam
Journal:  Molecules       Date:  2020-10-13       Impact factor: 4.411

8.  Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1.

Authors:  Sarah M Davis; Vignesh N Hariharan; Agnes Lo; Anton A Turanov; Dimas Echeverria; Jacquelyn Sousa; Nicholas McHugh; Annabelle Biscans; Julia F Alterman; S Ananth Karumanchi; Melissa J Moore; Anastasia Khvorova
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

9.  RNAi induces innate immunity through multiple cellular signaling pathways.

Authors:  Zhongji Meng; Xiaoyong Zhang; Jun Wu; Rongjuan Pei; Yang Xu; Dongliang Yang; Michael Roggendorf; Mengji Lu
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

10.  Design of siRNA Therapeutics from the Molecular Scale.

Authors:  Phillip Angart; Daniel Vocelle; Christina Chan; S Patrick Walton
Journal:  Pharmaceuticals (Basel)       Date:  2013
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.